Speech digital biomarker combined with fluid biomarkers can predict Alzheimer’s type cognitive impairment through machine learning

The combination of speech, blood biomarkers, and machine learning technologies provides valuable opportunities for the development of advanced disease prediction strategies, and we hope that in the era of monoclonal antibody drugs, better prediction strategies can promote large-scale early screening in the population, thereby improving patient treatment outcomes.